Intelligent Bio Solutions Inc. announced recent growth highlights across its global operations, with the total number of active accounts surpassing 450, including 35 new accounts added in fiscal Q3 alone. The Intelligent Fingerprinting Drug Screening System continues to gain traction for its speed, portability, and ease of use.
Recent commercial milestones include entry into the luxury marine sector in Europe, expansion into regional and remote testing programs in Australia, and new adoption within Australia’s waste and recycling sector, including pre-employment and for-cause testing. The company also penetrated the retail sector in Australia, including a major e-commerce brand.
INBS is strengthening its distributor ecosystem, with its global network now spanning 19 countries through 18 partners, enabling localized support and faster market access. These milestones build on the company’s strategic expansion efforts across high-potential industries and regions, strengthening its foundation ahead of its planned entry into the U.S. market.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.